Sheri Dodd, MSc.
Vice President & General Manager, Medtronic Care Management Services
Life, Liberty and the Pursuit of Value-Based Care Management
The decentralization of care delivery is in overdrive. Anytime, anywhere access to health services is in high demand and collaborative workflow across care providers is not only viewed as cost effective but a key driver for delivering on improved outcomes. Telehealth services, including remote patient monitoring, telemedicine and mHealth, have the ability to a drive a new patient and clinician experience. In this session you will hear about the transformation occurring in digital health and the role it plays in a value-based healthcare environment.
What you’ll learn:
- How new payment models are shaping the way patient care is delivered and measured
- The challenges and opportunities for technology, data, data analytics and clinical services
- Partnership and leadership requirements to win and deliver value
Ms. Dodd has over 23 years of experience in healthcare, bridging functional and business leadership roles across the pharmaceutical, medical device and international public health sectors. In June 2015, Sheri was appointed as the Vice President and General Manager for the Medtronic Care Management Services (MCMS). The MCMS business includes patient monitoring services, a value-based healthcare solution for improving outcomes and reducing the total cost of care for all levels of acuity and across multiple disease states. In her role, she also provides leadership to new business model creation in the area of post-acute care. Sheri joined Medtronic in March 2010 and had leadership responsibilities for the global Clinical Research organization and the Health Economics, Reimbursement, and Health Policy organization within the Cardiac Rhythm & Heart Failure (CRHF) business. In 2014, she had additional responsibilities as Vice President, Economic Value for the Cardiac and Vascular Group (CVG). Prior to joining Medtronic, Sheri spent 13 years at Johnson & Johnson in a variety of regional and global pharmaceutical and medical device positions focused on health economics, reimbursement and value proposition development and dissemination for external stakeholders. Prior to joining Industry, Sheri spent 5 years at the World Health Organization in Geneva, Switzerland and after returning to the US she worked in an office-based clinical practice, leading the implementation of clinical office-based outcomes research studies. Sheri earned a joint Master’s of Science degree from the London School of Economics and the London School of Hygiene and Tropical Medicine.